Atossa Therapeutics
ATOS
#9316
Rank
NZ$0.16 B
Marketcap
NZ$1.27
Share price
3.82%
Change (1 day)
-25.25%
Change (1 year)

Atossa Therapeutics (ATOS) - Cash on Hand

Cash on Hand as of September 2025 : NZ$90.03 Million

According to Atossa Therapeutics's latest financial reports the company has NZ$90.03 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Atossa Therapeutics - Cash on Hand chart (from 2010 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31NZ$0.12 B-9.89%
2023-12-31NZ$0.13 B-19.91%
2022-12-31NZ$0.17 B-12.52%
2021-12-31NZ$0.19 B264.22%
2020-12-31NZ$54.81 M193.45%
2019-12-31NZ$18.68 M20.71%
2018-12-31NZ$15.47 M52.28%
2017-12-31NZ$10.16 M132.48%
2016-12-31NZ$4.37 M-19.49%
2015-12-31NZ$5.42 M-49.96%
2014-12-31NZ$10.84 M40.58%
2013-12-31NZ$7.71 M268.01%
2012-12-31NZ$2.09 M-14.34%
2011-12-31NZ$2.44 M18322.47%
2010-12-31NZ$0.01 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Johnson & Johnson
JNJ
NZ$32.23 B 35,702.87%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
NZ$1.03 B 1,053.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
NZ$0.75 B 733.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
NZ$63.72 M-29.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Translate Bio
TBIO.defunct
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
NZ$0.28 B 216.55%๐Ÿ‡บ๐Ÿ‡ธ USA